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Introduction {#phy212845-sec-0001}
============

Elite endurance athletes frequently aim to enhance performance by executing training camps with increased training load (i.e., frequency, duration, and intensity) at sea‐level or at altitude inducing significant muscular stress with the potential risks for tissue damage (Meeusen et al. [2013](#phy212845-bib-0013){ref-type="ref"}) and impaired immune health (Walsh et al. [2011](#phy212845-bib-0021){ref-type="ref"}). The individual monitoring of training loads, especially during high‐altitude training (Chapman [2013](#phy212845-bib-0006){ref-type="ref"})**,** is essential for optimizing adaptation and performance as well as reducing the risk of chronic fatigue (Kiely [2012](#phy212845-bib-0011){ref-type="ref"}; Halson [2014](#phy212845-bib-0007){ref-type="ref"}).

A recent review concluded that particularly at altitude, (1) some athletes struggle compared to others when exposed to hypoxia; and (2) cautious screening may aid to identify such athletes (Chapman [2013](#phy212845-bib-0006){ref-type="ref"}). In this context, several objective and subjective stress markers have been proposed to monitor the individual training load at sea‐level and altitude (Banfi et al. [2012](#phy212845-bib-0001){ref-type="ref"}; Chapman [2013](#phy212845-bib-0006){ref-type="ref"}; Halson [2014](#phy212845-bib-0007){ref-type="ref"}), thereby, securing optimal adaptation and counteracting unwanted side effects such as overtraining symptoms. However, not every biomarker resembles as legitimate or sensitive variable for monitoring the stress of training (Halson [2014](#phy212845-bib-0007){ref-type="ref"}). Sophisticated biochemical analysis (e.g., muscle biopsies, special blood analysis) is invasive, cost worthy, depends on a laboratory and takes too long time to analyze in order to react timely (i.e., reducing volume and/or exercise intensity in subsequent training session) when chronic fatigue occurs. Therefore, from a practical point of view, subjective and objective biomarkers should be assessed in a set of markers and each marker should be assessed effortlessly and with rapid reporting of simple, yet scientifically trustworthy, feedback. From this perspective, point‐of‐care‐testing (POCT) allows simple assessment of biomedical parameters which can be performed at the bedside or on the training site providing convenient and immediate information to the athlete. In the present case study, we intended (1) to individually estimate the training response and to counteract chronic overreaching by applying promising POCT‐derived biomarkers; and (2) to discuss the practical applications of these variables for monitoring training load during 3 weeks of altitude training from elite German middle‐ and long‐distance runners.

Case Report {#phy212845-sec-0002}
===========

Nine members (7 male and 2 female) of the German middle‐ and long‐distance national team (age: 22 ± 3 years; size: 181.1 ± 8.9 cm; body mass: 67.2 ± 10.8 kg; the individual performance is summarized in Table [1](#phy212845-tbl-0001){ref-type="table-wrap"}) performed a 21 day altitude training camp (\~2100 m above sea‐level in Flagstaff, AZ) after a west‐bound flight with approximately 20--23 h of air and car transportation including a time shift of 9 h.

###### 

Performance of the athletes

  Athlete   400 m \[s\]   800 m \[min:s\]   1.500 m \[min:s\]   3.000 m \[min:s\]   5.000 m \[min:s\]   10.000 m \[min:s\]   Half Marathon \[h:min:s\]   Marathon \[h:min:s\]
  --------- ------------- ----------------- ------------------- ------------------- ------------------- -------------------- --------------------------- ----------------------
  1                       \<1:47            \<3:44                                                                                                       
  2         \<47.9        \<1:47                                                                                                                         
  3                       \<1:51            \<3:42                                                                                                       
  4                                         \<3:44              \<8:10                                                                                   
  5                                                                                 \<16:15             \<32:50              \<1:14:40                   \<2:28:30
  6                                                                                                     \<29:35              \<1:04:50                   \<2:16:10
  7                       \<1:49                                                                                                                         
  8                                         \<4:12              \<9:09              \<16:10                                                              
  9                                         \<3:42                                                                                                       
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The training camp was designed as a preseason preparation block. Two of the athletes participated in middle distance Olympic events and the others in national or international races. All procedures were in accordance with the declaration of Helsinki and the institute\'s ethical board, and all athletes gave their consent to participate in this study.

During the morning routine, all athletes reported to a field laboratory between 7 and 9 [am]{.smallcaps} in a fasting condition. Daily examination included: resting oxygen saturation of hemoglobin (typical error measurement (TEM): ≤1.5%) and resting heart rate (TEM: ≤2.5%; Masimo Rad‐5V Pulse Oximeter), body mass (TEM: ≤1.0%; Tanita BC 418 MA, Tokio, Japan), self‐reported body and sleep perception (1--6 scale, one being perfect), capillary blood concentration of creatine kinase (TEM: ≤3.8%; Spotchem EZ Sp 4430, Arkray, Kyoto, Japan). Every other day, venous serum concentration of blood urea nitrogen (TEM: ≤3.1%; Spotchem EZ Sp 4430) as well as venous blood concentration of hemoglobin and hematocrit (TEM: ≤1.5% and ≤2.0%), red and white blood cell count (TEM: ≤2.0% and ≤3.5%; Sysmex KX 21‐N, Sysmex, Kobe, Japan) were assessed. No data were obtained on day 12 due to a day‐long desert hike (Sperlich et al. [2010a](#phy212845-bib-0019){ref-type="ref"}).

At day 4 and 21, all athletes performed an incremental field step tests (4 × 2000 m with an initial speed of 4.0 m sec^−1^ and increase: 0.2 m sec^−1^ per interval) on a 400 m track to assess running speed at 3 mmol L^−1^ blood lactate (V~3~; TEM: ≤1.0%; Biosen C_line, EKF Diagnostics, Germany). V~3~ was calculated by linear extrapolation, using the lactate concentration at the running velocities directly before and after the achievement of 3 mmol L^−1^ capillary blood lactate concentration.

The training program for all 21 days is summarized in Table [2](#phy212845-tbl-0002){ref-type="table-wrap"}.

###### 

Training volume and intensity of all morning and afternoon training sessions without warm‐up

  Day   Morning session                   Afternoon session                                                                              Training time \[min\]   Volume \[km\]
  ----- --------------------------------- ---------------------------------------------------------------------------------------------- ----------------------- ---------------
  0     Arrival                           Assembly of field laboratory                                                                                           
  1     40 min easy jogging               40 min at 70% of V~3~                                                                          80                      7.5
  2     2 h hiking                        10 km at 80% of V~3~                                                                           180                     18
  3     10 km at 82% of V~3~              2 h hiking                                                                                     180                     18
  4     4 × 2000 m incremental test       Core strength                                                                                  180                     12
  5     18 km at 82% of V~3~                                                                                                             120                     18
  6     10 km at 82% of V~3~              10 × 200 m uphill intervals at \<85% race pace with 2 min recovery (walking or easy jogging)   150                     18
  7     8 × 1000 m at 100--105% of V~3~   45 min at 70% of V~3~                                                                          150                     17
  8     15 km at 83% of V~3~              Core strength                                                                                  90                      16
  9     15 km at 83% of V~3~              Core strength                                                                                  180                     17
  10    1 h at 80% of V~3~                1 h at 82% of V~3~                                                                             180                     26
  11    10 km at V~3~                     45 min at 70% of V~3~                                                                          150                     19
  12    Hiking Grand Canyon                                                                                                              500                     33
  13    1 h 83%V3                         10 × 200 m uphill intervals at 88% race pace with 2 min recovery (walking or easy jogging)     150                     18
  14    8 × 1000 m 105--110% of V~3~      45 min at 70% of V~3~                                                                          150                     17
  15    15 km at 83% of V~3~                                                                                                             90                      16
  16    10--12 km at 87% of V~3~          Core strength                                                                                  180                     13
  17    1 h at 82% of V~3~                                                                                                               90                      14
  18    10 km at V~3~                     45 min at 70% of V~3~ and core strength                                                        150                     19
  19    15--20 km at 83% of V~3~                                                                                                         72                      15
  20    1 h at 82% of V~3~                10 × 200 m uphill intervals at 90% race pace with 2 min recovery (walking or easy jogging)     150                     18
  21    4 × 2000 m incremental test       45 min at 70% of V~3~                                                                          180                     14
  22    Departure                                                                                                                                                

V~3~ = Running speed corresponding to 3 mmol L^−1^ of blood lactate.
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As a general training rule, training load (volume and/or exercise intensity) was reduced when two or more of the above‐mentioned stress markers were outside the normal individual range of the athlete. We did not record the specific training adjustments since they occur frequently and are based on the coaches' and athletes' experience. The normal individual ranges (mean ± standard deviation) for each variable and each athlete were quantified based on the values derived from the data of day 1 and/or matched with the individual data obtained from previous monitoring. All mean ± SD data for each variable and each day of all athletes during 3‐weeks altitude training are presented in Table [3](#phy212845-tbl-0003){ref-type="table-wrap"}.

###### 

Mean ± SD data for each variable and each day of all athletes during 3‐weeks altitude training

                                                                  1       2       3       4       5       6       7       8       9       10      11      12   13      14      15      16      17      18      19      20
  --------------------------------------------------------------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ---- ------- ------- ------- ------- ------- ------- ------- -------
  Oxygen saturation \[%\]                                                                                                                                                                                              
  Mean                                                            96.8    97.0    96.1    96.2    95.8    95.9    96.2    96.9    95.7    96.7    95.4         97.4    97.2    97.4    96.2    97.0    96.4    96.6    96.4
  SD                                                              0.8     1.2     1.4     1.4     1.1     0.9     1.0     1.5     0.9     1.1     1.5          1.4     1.4     1.3     1.4     1.4     1.1     0.9     1.9
  Heart rate at rest \[bpm\]                                                                                                                                                                                           
  Mean                                                            58.3    60.9    54.6    62.7    57.6    59.3    54.6    54.2    51.0    57.1    51.3         49.2    52.1    48.0    49.3    48.2    50.2    48.1    50.3
  SD                                                              9.5     11.1    10.7    8.6     10.3    12.0    7.7     7.1     6.2     8.6     5.8          9.7     11.8    6.5     8.3     4.9     7.6     5.9     5.2
  Body mass \[kg\]                                                                                                                                                                                                     
  Mean                                                            66.3    66.7    66.7    66.6    66.6    66.7    66.3    66.7    66.5    66.9    66.7         66.5    66.6    66.7    66.7    66.6    66.7    66.6    66.6
  SD                                                              10.8    10.7    10.6    10.9    10.4    10.6    10.6    10.8    10.6    11.0    10.6         10.4    10.5    10.5    10.5    10.2    10.6    10.7    10.3
  Quality of sleep \[a.u.\]                                                                                                                                                                                            
  Mean                                                            2.1     2.5     2.6     1.8     2.9     2.0     2.6     2.9     2.4     2.3     2.3          2.2     2.7     2.9     2.0     2.9     2.6     2.3     2.8
  SD                                                              0.8     0.5     0.5     1.0     1.5     1.0     0.9     1.2     0.9     0.5     1.0          1.1     1.1     1.3     1.0     1.8     0.7     0.5     1.3
  Body perception \[a.u.\]                                                                                                                                                                                             
  Mean                                                            2.7     2.4     2.6     2.8     2.8     2.6     2.8     2.9     2.6     2.3     2.6          2.7     2.3     2.6     2.3     2.5     2.4     2.6     3.0
  SD                                                              0.8     0.5     0.7     1.0     0.5     0.7     0.5     0.6     0.5     0.5     0.5          0.9     0.5     0.5     0.5     0.5     0.5     1.0     1.0
  Creatine kinase \[U L^−1^\]                                                                                                                                                                                          
  Mean                                                            182.2   260.6   321.3   372.2   395.3   449.2   366.6   314.9   451.8   405.1   413.3        271.9   351.2   331.2   262.9   450.0   434.7   341.1   336.7
  SD                                                              75.9    112.7   125.5   119.5   141.4   155.0   140.4   110.2   183.6   200.4   174.3        107.9   169.7   137.0   108.4   166.7   197.9   151.1   180.9
  Blood urea nitrogen \[mmol L^−1^\]                                                                                                                                                                                   
  Mean                                                            4.2             4.5             4.8             5.0             5.0             4.1                          3.8             3.8             3.7     
  SD                                                              1.8             1.0             0.8             1.6             1.2             0.9                          1.0             0.7             1.0     
  Hemoglobin \[g·dL‐1\]                                                                                                                                                                                                
  Mean                                                            16.4            16.1            16.6            16.3            16.0            16.0         16.4            16.4            16.3            16.5    
  SD                                                              0.7             1.0             0.8             0.5             0.8             0.8          0.9             0.7             1.0             0.9     
  Hematocrit \[%\]                                                                                                                                                                                                     
  Mean                                                            47.7            46.0            47.9            46.8            45.4            45.6         46.7            47.1            46.2            47.3    
  SD                                                              1.7             2.5             2.0             1.6             2.1             1.9          2.2             1.7             2.5             2.6     
  Red blood cells count \[×10e6 *μ*L^−1^\]                                                                                                                                                                             
  Mean                                                            5.5             5.3             5.6             5.4             5.4             5.4          5.4             5.4             5.6             5.4     
  SD                                                              0.3             0.4             0.4             0.3             0.4             0.3          0.5             0.4             0.4             0.5     
  White blood cells count \[×10e6 *μ*L^−1^\]                                                                                                                                                                           
  Mean                                                            6.0             5.8             6.2             5.6             5.5             6.0          5.5             5.6             6.3             6.4     
  SD                                                              0.9             0.9             0.8             1.1             0.8             1.0          0.9             0.8             0.9             1.8     
  Running speed at 3 mol L^−1^ (V3) blood lactate \[m sec^−1^\]                                                                                                                                                        
  Mean                                                                                    4.50                                                                                                                         4.63
  SD                                                                                      0.30                                                                                                                         0.27
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In the present case study, V~3~ increased from day 4 to day 21 (4.4 ± 0.3 to 4.6 ± 0.3 m sec^−1^). None of the athletes showed or reported any signs of underperformance, chronic muscle damage, decreased body and sleep perception during the 21 days of exercise. Only athlete 3 showed signs of inflammation (elevated WBC; Fig. [1](#phy212845-fig-0001){ref-type="fig"}) on day 19 following an accident involving widespread open leg wounds.

![The mean (red line or dot) and individual day‐to‐day variation of different stress and performance markers of nine elite athletes during a 21 day training camp.](PHY2-4-e12845-g001){#phy212845-fig-0001}

Discussion {#phy212845-sec-0003}
==========

It is well known that persistent exposure to hypoxia and increased training loads have detrimental effects on body mass (Westerterp and Kayser [2006](#phy212845-bib-0023){ref-type="ref"}), muscle architecture (Howald and Hoppeler [2003](#phy212845-bib-0010){ref-type="ref"}), and exercise capacity (Baquet et al. [2002](#phy212845-bib-0002){ref-type="ref"}), however, none of our athletes showed any loss in body mass nor exercise capacity. In fact, the V~3~ slightly improved over time which could be due to metabolic adaptation or a result of a phenomenon called lactate paradox (a yet unclear observation showing lower‐than‐expected amounts of lactate) when exposed to hypoxia (Hochachka et al. [2002](#phy212845-bib-0009){ref-type="ref"}).

Additionally, a rapid elevation in volume and/or exercise intensity for a sustained period, as designed in this study, has the potential to result in "overreaching" or symptoms related to overtraining (Baquet et al. [2002](#phy212845-bib-0002){ref-type="ref"}; Smith [2003](#phy212845-bib-0018){ref-type="ref"}; Schmitt et al. [2006](#phy212845-bib-0017){ref-type="ref"}). This may lead to reduced maximum physical capacity (Baquet et al. [2002](#phy212845-bib-0002){ref-type="ref"}) or chronic performance decrements including chronic fatigue symptoms (i.e., exhausted feeling, tiredness, lack of energy with impaired sleep, lower immunity, or inflammation processes) (Montpetit et al. [1987](#phy212845-bib-0014){ref-type="ref"}; Ryan et al. [1987](#phy212845-bib-0016){ref-type="ref"}; Sperlich et al. [2010b](#phy212845-bib-0020){ref-type="ref"}).

Usually, stress markers such as creatine kinase, urea, hemoglobin concentration, hematocrit, red and white blood cells are measured in longer time intervals or when underperformance occurs. However, in training camps with demanding training loads, it is paramount to timely counteract negative side effects such as chronic muscle damage or underperformance. Consequently, during training camps, easy and fast determinable parameters should be assessed on a daily basis in order to control training load. CK and blood urea nitrogen are a blood‐borne biomarkers (easily measured with POCT with rapid feedback to the athlete) and have shown to accurately reflect changes in fatigue during a training camp (Hecksteden et al. [2016](#phy212845-bib-0008){ref-type="ref"}). Blood cell counts and measuring of hemoglobin concentration cannot detect overreaching or underperformance per se; however, these variables are helpful in providing information on the actual health status of the athlete (Robson‐Ansley et al. [2009](#phy212845-bib-0015){ref-type="ref"}) and should be frequently assessed to ensure a good health status.

Based on the current data, the mean heart rate decreased from Day 1 to the end of the training camp, which is a normal sign during altitude exposure (Mazzeo [2008](#phy212845-bib-0012){ref-type="ref"}) as well as of positive aerobic training adaptations. However, the interpretation of repeated measures of heart rate at rest (Buchheit [2014](#phy212845-bib-0005){ref-type="ref"}) over time may be complex since the heart rate is influence by cardiac structure, plasma volume, autonomic activity, age, body position, and oxygen partial pressure.

Additionally, continuous exposure to hypoxia has opposing effects on mental functioning and quality of sleep (Weil [2004](#phy212845-bib-0022){ref-type="ref"}), and together can negatively impact the quality of a training and general well‐being. Although none of our athletes reported overtraining symptoms, several athletes complained of impaired sleep which is a well‐known side effect among athletes in altitude training camps. For this reason, simple questionnaires with fatigue and sleep‐related scales represent simple and inexpensive measures to estimate the training load and subsequent responses to training. However, questionnaires and fatigues scales rely on subjective information, which need to be verified with physiological data, as pointed out earlier (Borresen and Lambert [2009](#phy212845-bib-0004){ref-type="ref"}).

For this reason, during long‐term diagnostic, we defined individual ranges for all subjective and objective variables. In the case two or more of the above‐mentioned stress markers were beyond or beneath the normal range for the athletes, training load (i.e., intensity or volume) was reduced the subsequent day. This procedure was based on experiences obtained from numerous training interventions and recommendations summarized previously (Halson [2014](#phy212845-bib-0007){ref-type="ref"}). From a scientific point of view, we cannot be sure whether this procedure may be superior to other marker sets or data interpretation, however, from a practical point of view, this procedure allowed us (1) to improve V~3~; and (2) timely counteract signs of possible chronic overreaching with no signs of activated inflammatory process (except for athlete 3 on day 19) and loss of sleep.

Some limitations of this case study are noteworthy. Although the training load adjustments were based on our screening including the judgment and experience of the coach and the athlete, we cannot prove that the performance was affected by the change in training load. Potentially no athlete would have developed symptoms, even if the training load was unaltered. Since we did not include a control group, we cannot confirm if the procedures presented here were superior to others to improve performance. However, a different study design including a control group involving elite‐level athletes is practically impossible since novel training modifications might not result in performance gains or might even lead to overtraining symptoms.

The adjustment of intensity and volume in elite runners by screening of selected biomarkers as described in the present case study may stimulate further research to identify candidate markers for load monitoring in elite middle‐ and long‐distance runners during a high‐altitude training camp.
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